Professor Daniel C. Baumgart, MD, PhD, MBA, FEBG, FACP, FRCP (London), AGAF completed his medical education in Berlin, Basel, and Würzburg. He received training in internal medicine, gastroenterology, hepatology, and immunology at Charité (Medical School of Humboldt University in Berlin) and as a scholar of the German Academic Exchange Service (DAAD) and the German Research Foundation (DFG) at the University of Pennsylvania, Philadelphia, PA, Georgetown University, Washington, DC, and the National Institutes of Health (NIH), Bethesda, MD, USA.

He is a Professor of Medicine at Charité. Until 2017, he served as Deputy Chief of the Department of Gastroenterology and Hepatology at Virchow Hospital and was an elected Fellow at the Berlin Institute of Health (BIH), endowed by the StiftungCharité foundation. In 2023, he was appointed Chief of the Department of Gastroenterology, Hepatology, Infectious Diseases, and Rheumatology at Ernst von Bergmann Hospital.

Since 2017, he has also been a Professor of Medicine at the University of Alberta in Edmonton, Canada. Under his leadership, the Division of Gastroenterology, which he directed until 2022, achieved a ranking of No. 1 at the University of Alberta, No. 2 in Canada, and No. 28 worldwide in the Best Global Universities ranking by U.S. News & World Report. He has also been a Visiting Professor at Yale University, New Haven, CT, and Harvard University, Boston, MA, USA.

As an internationally renowned expert in inflammatory bowel diseases (IBD), Professor Baumgart is dedicated to developing innovative diagnostic and therapeutic strategies for Crohn's disease and ulcerative colitis, as exemplified in his publication in the New England Journal of Medicine. He has served as Principal Investigator for over 200 clinical trials spanning Phases I through IV and is a Co-Principal Investigator in the Inflammation, Microbiome & Alimentation, Gastro-Intestinal & Neuropsychiatric Effects Specific Patient-Oriented Research (IMAGINE-SPOR) network.

A pioneer in the digital transformation of medicine, he is also an Adjunct Professor of Computer Science at the Faculty of Science, Department of Computing Science at the University of Alberta. He is a founding member of the University of Alberta Precision Health and AI4Society Signature Areas. Among his many achievements, he established Alberta's first digital big-data patient registry.

With over two decades of engagement in digital innovations, artificial intelligence (AI), and decision-support systems, he has championed the integration of personalized precision medicine and targeted therapies into clinical practice. In a Nature Portfolio Digital Medicine article, he analyzes the advantages of Canada's largest fully integrated digital health system in Alberta for crisis management, public health, and accelerating digital innovations in healthcare and life sciences.

Furthermore, he serves as Principal Investigator and Program Director of the international Collaborative Research and Traininge Experience program From Data to Decision (FD2D) - Digital Transformation and Artificial Intelligence from Data Value Chain to Human Value. This research and training initiative unites scientists and developers from 22 leading academic institutions and technology enterprises across North America, Europe, and Asia to explore digital transformation and AI applications across multiple disciplines and industries. The program is funded by the Natural Sciences and Engineering Research Council of Canada (NSERC), Mathematics of Information Technology and Complex Systems (Mitacs), and the University of Alberta. His research is conducted in collaboration with the Alberta Machine Intelligence Institute, the Kule Institute for Advanced Study, and the Alberta Health Services Chief Medical Information Office, with financial support from the Canadian Institute of Advanced Research (CIFAR), the Canadian Institutes of Health Research (CIHR), the Social Sciences and Humanities Research Council of Canada (SSHRC), the University Hospital Foundation, and Alberta Innovates.

In 2023, at the invitation of the German Federal Ministry of Health, Professor Baumgart contributed expert insights at the Data for Health conference in Berlin and its follow-up workshop at Harvard University in Boston, where he collaborated with leading decision-makers from academia, society, and policy. In an invited commentary for the U.S. National Academy of Sciences Journal, he shared his perspective on the integrity of health data, and in an article for The Lancet, he highlighted the benefits of data sharing.

Professor Baumgart serves as Deputy Editor of Nature Portfolio Digital Medicine and Associate Editor of The Lancet, Gut, and Inflammatory Bowel Diseases. He also chairs the AI in IBD Working Group of the European Crohn’s and Colitis Organisation (ECCO) and is a member of numerous national and international expert committees.

As an alumnus of the BMW Foundation Herbert Quandt, he is deeply committed to responsible leadership and fostering the next generation of scientists. His Clinician Scientist training concept for integrated clinical and scientific education, recognized under the Off the Beaten Track program of the Volkswagen Foundation, has been endorsed as a national model program for academic medicine by the German Research Foundation (DFG), the German Federal Ministry of Education and Research (BMBF), and the German Council of Science and Humanities (WR).

In recognition of his contributions, Professor Baumgart was named a Fellow of the American College of Physicians (FACP) in 2013, a Fellow of the American Gastroenterological Association (AGAF) in 2014, and a Fellow of the Royal College of Physicians (FRCP, London) in 2017.